Log in

Magellan Health Stock Price, News & Analysis (NASDAQ:MGLN)

$62.40
-0.10 (-0.16 %)
(As of 10/20/2019 10:36 AM ET)
Today's Range
$61.08
Now: $62.40
$62.41
50-Day Range
$58.11
MA: $61.59
$64.93
52-Week Range
$51.88
Now: $62.40
$75.87
Volume68,179 shs
Average Volume175,516 shs
Market Capitalization$1.52 billion
P/E Ratio25.57
Dividend YieldN/A
Beta0.61
Magellan Health, Inc provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. Read More…

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNASDAQ:MGLN
CUSIP55907920
Phone602-572-6050

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.31 billion
Cash Flow$8.04 per share
Book Value$52.99 per share

Profitability

Net Income$24.18 million

Miscellaneous

Employees10,500
Market Cap$1.52 billion
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.


Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) posted its quarterly earnings data on Tuesday, July, 30th. The company reported $0.86 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.92 by $0.06. The company had revenue of $1.79 billion for the quarter, compared to analysts' expectations of $1.75 billion. Magellan Health had a net margin of 0.18% and a return on equity of 3.68%. The business's revenue for the quarter was down 1.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.92 earnings per share. View Magellan Health's Earnings History.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health updated its FY19 earnings guidance on Tuesday, July, 30th. The company provided earnings per share (EPS) guidance of $3.70-$4.69 for the period, compared to the Thomson Reuters consensus estimate of $4.01. The company issued revenue guidance of $7.0-$7.2 billion, compared to the consensus revenue estimate of $7.10 billion.

What price target have analysts set for MGLN?

4 equities research analysts have issued 1-year price targets for Magellan Health's stock. Their forecasts range from $68.00 to $84.00. On average, they expect Magellan Health's stock price to reach $73.50 in the next year. This suggests a possible upside of 17.8% from the stock's current price. View Analyst Price Targets for Magellan Health.

What is the consensus analysts' recommendation for Magellan Health?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health.

Has Magellan Health been receiving favorable news coverage?

Media headlines about MGLN stock have been trending somewhat positive on Sunday, according to InfoTrie. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Magellan Health earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Magellan Health.

Are investors shorting Magellan Health?

Magellan Health saw a drop in short interest in the month of September. As of September 30th, there was short interest totalling 638,500 shares, a drop of 17.6% from the August 30th total of 774,900 shares. Based on an average trading volume of 230,100 shares, the short-interest ratio is presently 2.8 days. Currently, 2.7% of the shares of the company are sold short. View Magellan Health's Current Options Chain.

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:
  • Mr. Barry Morgan Smith, Chairman, CEO & CEO of Magellan Healthcare (Age 65)
  • Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)
  • Mr. Daniel Norman Gregoire, Gen. Counsel & Sec. (Age 63)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Smith Graham & Co. Investment Advisors LP (0.74%), Assenagon Asset Management S.A. (0.12%), State of Alaska Department of Revenue (0.07%), Pacer Advisors Inc. (0.03%), Alpha Windward LLC (0.02%) and Summit X LLC (0.02%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Which major investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc. and Alpha Windward LLC. View Insider Buying and Selling for Magellan Health.

Which major investors are buying Magellan Health stock?

MGLN stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Smith Graham & Co. Investment Advisors LP, State of Alaska Department of Revenue, Pacer Advisors Inc., Summit X LLC and Robeco Institutional Asset Management B.V.. View Insider Buying and Selling for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $62.40.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.52 billion and generates $7.31 billion in revenue each year. The company earns $24.18 million in net income (profit) each year or $2.44 on an earnings per share basis. Magellan Health employs 10,500 workers across the globe.View Additional Information About Magellan Health.

What is Magellan Health's official website?

The official website for Magellan Health is http://www.magellanhealth.com/.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  326 (Vote Outperform)
Underperform Votes:  340 (Vote Underperform)
Total Votes:  666
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Featured Article: What are Bollinger Bands?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel